Raccomandazioni - Mercato USA - H.C. WAINWRIGHT

Raccomandazioni operative su titoli azionari del Mercato USA, emesse dalla società H.C. WAINWRIGHT.

Tutte le emittenti ALLIANCE GLOBAL PARTNERS ASCENDIANT B. RILEY BANK OF AMERICA SECURITIES BARCLAYS BBVA BENCHMARK BERNSTEIN BMO CAPITAL BNP PARIBAS BRADESCO BROOKLINE CAPITAL BTIG BWS FINANCIAL CANNONBALL RESEARCH CANTOR FITZGERALD CAPITAL ONE FINANCIAL CBRE CIBC CICC CITIGROUP CJS SECURITIES CLSA COMPASS POINT COWEN & CO. CRAIG-HALLUM D.A. DAVIDSON DAIWA DANSKE BANK DBS BANK DESJARDINS DEUTSCHE BANK EMPIRE ASSET MANAGEMENT EVERCORE ISI EXANE BNP PARIBAS FBN SECURITIES FERMIUM RESEARCH FIRST SHANGHAI FOX ADVISORS GF SECURITIES GLJ RESEARCH GOLDMAN SACHS GUGGENHEIM H.C. WAINWRIGHT HOVDE GROUP HSBC HUBER RESEARCH INVESTEC ITAU BBA JEFFERIES JOHNSON RICE KANSAS CITY CAPITAL KEEFE, BRUYETTE & WOODS KEYBANC KGI SECURITIES LAIDLAW LAKE STREET LITCHFIELD HILLS LOOP CAPITAL MARKETS MACQUARIE MAXIM GROUP MITSUBISHI UFJ MOFFETTNATHANSON MONNESS MORGAN STANLEY NATIONAL BANK NEEDHAM NEW STREET NOBLE CAPITAL MARKETS NOMURA NORDEA ODDO BHF OPPENHEIMER PARETO PIPER SANDLER PIVOTAL RESEARCH RAYMOND JAMES RBC CAPITAL RODMAN & RENSHAW ROTH CAPITAL SANTANDER SCOTIABANK SEAPORT GLOBAL STEPHENS SUMMIT INSIGHTS GROUP SUNTRUST ROBINSON HUMPHREY SUSQUEHANNA TD SECURITIES TELSEY ADVISORY TIGRESS FINANCIAL TRUIST FINANCIAL UBS US TIGER SECURITIES VERTICAL RESEARCH WBB SECURITIES WEDBUSH WELLS FARGO WESTPARK CAPITAL WILLIAM BLAIR WOLFE RESEARCH ZELMAN

Società	Giudizio	Emittente	Data
OVID THERAPEUTICS INC	+ BUY	H.C. WAINWRIGHT	11/09/2026
SAREPTA THERAPEUTICS INC	- SELL	H.C. WAINWRIGHT	08/09/2026
SERNOVA CORP	+ BUY	H.C. WAINWRIGHT	08/09/2026
TSCAN THERAPEUTICS INC	= NEUTRAL	H.C. WAINWRIGHT	08/09/2026
WESTERN COPPER AND GOLD CORP	+ BUY	H.C. WAINWRIGHT	04/09/2026
MILESTONE PHARMACEUTICALS INC	+ BUY	H.C. WAINWRIGHT	04/09/2026
LEGEND BIOTECH CORP	+ BUY	H.C. WAINWRIGHT	04/09/2026
UBER TECHNOLOGIES INC	+ BUY	H.C. WAINWRIGHT	02/09/2026
HALOZYME THERAPEUTICS INC	+ BUY	H.C. WAINWRIGHT	02/09/2026
BIOMARIN PHARMACEUTICAL INC	= NEUTRAL	H.C. WAINWRIGHT	31/08/2026

Ultime 10 raccomandazioni.